Search

everythinglearnresearchcommunity

for

Search:↓

Personalized treatment considering atopic status and cytokine profiles may help in managing pediatric alopecia areata.

Sex and race affect immune responses and treatment outcomes in Hidradenitis suppurativa.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

Unique microRNA patterns can help diagnose and treat severe alopecia areata.

Alopecia areata involves unique activation of certain immune cells.

Anti-Ku-positive patients often have muscle weakness and autophagy plays a key role in their condition.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

The case shows how hard it is to tell apart Multiple Autoimmune Syndrome from other similar autoimmune conditions, but correct diagnosis is key for treatment to work.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

Trichohyalin may trigger the immune response causing alopecia areata.

Machine learning can help find new ways to treat alopecia areata.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

The girl's condition improved with treatment, showing no new autoimmune diseases and hair regrowth.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

A 22-year-old with multiple autoimmune diseases needs a multidisciplinary treatment approach.

Belimumab may cause hair loss in lupus patients.

A new diagnostic model can help better diagnose and understand Alopecia Areata.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

A man with four autoimmune diseases suggests a new category for multiple autoimmune syndrome.

A 16-year-old girl with lupus symptoms improved with treatment despite negative ANA tests.

Machine learning can use blood tests to help predict moderate-to-severe alopecia areata.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

Melanocytes might be targeted by the immune system in people with alopecia areata, but more research is needed.

Women with PCOS are more likely to have thyroid antibodies than those without.

Alopecia areata often starts before age 20, is more common in women, and may have a genetic link with other autoimmune diseases.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Dermatologists vary widely in testing practices for alopecia areata, often exceeding guideline recommendations.